TNF and osteosarcoma: Cells from two minimally-passaged human osteosarcomas were quite sensitive to Smac mimetic/TNFα co-treatment, however established human osteosarcoma cell lines varied substantially in their sensitivity to Smac mimetics as sole agents and together with TNFα.